5 Key Takeaways
-
1
Glaucoma management has traditionally been reactive, relying heavily on patient adherence to topical medications.
-
2
Interventional glaucoma (IG) management emphasizes early diagnostics and proactive interventions, including lasers and surgical options.
-
3
Selective laser trabeculoplasty (SLT) improves aqueous outflow, reducing the need for anti-glaucoma medications.
-
4
Sustained-release drug delivery platforms can provide medication over extended periods, enhancing patient compliance.
-
5
Adopting IG management aligns with a trend towards earlier interventions that prioritize long-term outcomes and quality of life.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


